Vim’s $24 Million Series B Financing

Fenwick & West advissed Vim Inc. on the deal.

Founded in 2015, Vim Inc. is a healthcare technology company that aligns incentives between health plans and care providers to empower value-based care decisions. Vim’s platform helps promote affordable, convenient, high-quality care by helping doctors choose the right care providers and guiding patients to optimal care providers through online booking. The company’s platform is powered by collective intelligence from health care data and human expertise.

Vim completed a $24 Million Series B financing round led by Optum Ventures and Premera Blue Cross. The round also included follow-on investments by Great Point Ventures and Sequoia Capital and an investment from Leverage Health Solutions.

Vim will use this investment to fuel rapid expansion across new U.S. markets, and accelerate product development and hiring initiatives.

Fenwick advised Vim with a team including partners Idan Nester and Michael Esquivel (Picture), as well as associates Alina Azizian and Lillian Icard.

Involved fees earner: Alina Azizian – Fenwick & West LLP; Michael Esquivel – Fenwick & West LLP; Lillian Icard – Fenwick & West LLP; Idan Nester – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: Vim Inc.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti